Thomas Miller
Plus aucun poste en cours
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Walker H. Colston | M | 63 | 21 ans | |
| Chris Williams | M | 62 | 16 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Victor Alston | M | 52 | 8 ans | |
| Alfred Mann | M | 98 | 18 ans | |
| Atul Bhatnagar | M | 66 | 5 ans | |
| Matthew Pfeffer | M | 67 | - | |
| Jonathan McGuire | M | 61 | - | |
| Anne-Marie Ripley | F | 54 | 11 ans | |
| Maik Lankau | M | - | - | |
| Laurent Asscher | M | 53 | 9 ans | |
| Gail Hamilton | F | 74 | 12 ans | |
| Jonathan Fram | M | 66 | 12 ans | |
| Stephen Okland | M | 60 | - | |
| Jon F. Rager | M | 84 | 16 ans | |
| Tim Jones | M | - | - | |
| Jim R. Smith | M | - | - | |
| Brent Novak | M | 51 | 14 ans | |
| Brian V. Mech | M | 55 | 16 ans | |
| Patti Key | F | - | - | |
| Anupam Sahai | M | - | - | |
| Raymond de Graaf | M | 57 | 7 ans | |
| James Miller | M | - | - | |
| Bob Holmen | M | 60 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 ans |
| Alan Grahame | M | 71 | 8 ans | |
| Doug Samuelson | M | 64 | 4 ans | |
| John Moses | M | 65 | 1 ans | |
| Cliff Hannel | M | 61 | - | |
| David Edward Anderson | M | 68 | 6 ans | |
| Robert W. Bass | M | 77 | 7 ans | |
| Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 ans |
| Alexander Pepe | M | 61 | - | |
| Massoud Entekhabi | M | 70 | - | |
| Alan Cuellar Amrod | M | 65 | - | |
| David Jacques | M | 61 | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 34 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Thomas Miller
- Réseau Personnel
